# Pilot Study of Velcade® in IgA Nephropathy

> **NCT01103778** · PHASE4 · COMPLETED · sponsor: **The Rogosin Institute** · enrollment: 11 (actual)

## Conditions studied

- Chronic Kidney Disease
- IgA Nephropathy

## Interventions

- **DRUG:** Bortezomib (Velcade®)

## Key facts

- **NCT ID:** NCT01103778
- **Lead sponsor:** The Rogosin Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2017-04-17
- **Final completion:** 2017-04-17
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103778, "Pilot Study of Velcade® in IgA Nephropathy". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01103778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*